Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 31.
doi: 10.1111/1471-0528.18351. Online ahead of print.

Differences in Risk Factors for Severe Preeclampsia and HELLP Syndrome in Singleton Versus Twin Pregnancies: A Population-Based Cohort Study

Mackenzie Campbell  1 , Johanna Koegl  2 , Jeffrey N Bone  3 , Sofia Nicolls  1 , Janet Lyons  1 , Chantal Mayer  1 , Kenneth I Lim  1 , Julie Van Schalkwyk  1 , K S Joseph  1   4 , Sarka Lisonkova  1   4 ; ORQA group
Collaborators, Affiliations

Differences in Risk Factors for Severe Preeclampsia and HELLP Syndrome in Singleton Versus Twin Pregnancies: A Population-Based Cohort Study

Mackenzie Campbell et al. BJOG. .

Abstract

Objective: To examine whether the associations between pre-pregnancy risk factors and severe preeclampsia/eclampsia (SPE) and/or HELLP syndrome differ between singleton and twin pregnancies.

Design: A population-based retrospective cohort study.

Setting: British Columbia (BC), Canada.

Population: All pregnancies with singletons or twins that resulted in a stillbirth or live birth at ≥ 20 weeks' gestation from 2008/09 to 2020/21.

Methods: Data were obtained from the BC Perinatal Database Registry. Logistic regression was used to estimate the association between each risk factor for SPE/HELLP (e.g., body-mass-index (BMI), in vitro-fertilisation (IVF), chronic hypertension, and diabetes) and the modifying effect of plurality by including interaction terms between these risk factors and plurality in the model.

Main outcome measures: Severe preeclampsia, eclampsia, and/or HELLP syndrome.

Results: Among 563 252 pregnancies (8841 twin, 554 411 singleton), the rate of SPE/HELLP was 4.7 per 1000 singleton pregnancies and 31.1 per 1000 twin pregnancies (relative risk 6.61; 95% confidence interval (CI) 5.84-7.49). Older maternal age (≥ 35 years), nulliparity, pre-pregnancy and gestational diabetes, chronic hypertension, prior mental health problems, substance use during pregnancy, and prior stillbirth increased the odds, while smoking decreased the odds of SPE/HELLP among both singleton and twin pregnancies. However, the adjusted associations between BMI, IVF, prior abortions, and SPE/HELLP differed by plurality (interaction p-values 0.002, < 0.0001, and 0.04, respectively). IVF was associated with increased odds of SPE/HELLP in singleton pregnancies (adjusted odds ratio (aOR) 1.93; 95% CI 1.64-2.27) but not in twins (aOR 0.85; CI 0.65-1.11). Similarly, overweight BMI was associated with elevated odds in singleton pregnancies (aOR 1.47; CI 1.32-1.64) but not in twins (aOR 0.86; CI 0.59-1.25), as was obese BMI (singleton aOR 1.88; CI 1.67-2.12; twin aOR 0.80; CI 0.51-1.24). Conversely, a history of prior abortions was associated with decreased odds in twin pregnancies (aOR 0.70; CI 0.54-0.92) but not singleton pregnancies (aOR 0.95; CI 0.88-1.04).

Conclusions: High BMI and IVF are associated with elevated risk of SPE/HELLP syndrome in singleton pregnancies, but not in twin pregnancies. This study provides insights regarding SPE/HELLP syndrome among singleton and twin pregnancies, and useful information for pre-pregnancy counselling.

Keywords: HELLP syndrome; multiple gestation; preeclampsia; twin pregnancyeclampsia.

PubMed Disclaimer

References

    1. J. A. Cresswell, M. Alexander, M. Y. C. Chong, et al., “Global and Regional Causes of Maternal Deaths 2009–20: A WHO Systematic Analysis,” Lancet Global Health 13, no. 4 (2025): e626–e634, https://doi.org/10.1016/S2214‐109X(24)00560‐6.
    1. K. S. Joseph, A. Boutin, S. Lisonkova, et al., “Maternal Mortality in the United States: Recent Trends, Current Status, and Future Considerations,” Obstetrics and Gynecology 137, no. 5 (2021): 763–771.
    1. S. Lisonkova, S. Bartholomew, J. Rouleau, S. Liu, R. M. Liston, and K. S. Joseph, “Temporal Trends in Maternal Mortality in Canada I: Estimates Based on Vital Statistics Data,” Journal of Obstetrics and Gynaecology Canada 33, no. 10 (2011): 1011–1019.
    1. A. M. Khedagi and N. A. Bello, “Hypertensive Disorders of Pregnancy,” Cardiology Clinics 39, no. 1 (2021): 77–90.
    1. L. A. Magee, G. N. Smith, C. Bloch, et al., “426: Hypertensive Disorders of Pregnancy: Diagnosis, Prediction, Prevention, and Management,” Journal of Obstetrics and Gynaecology Canada 44, no. 5 (2022): 547–571, https://doi.org/10.1016/j.jogc.2022.03.002.

LinkOut - more resources